DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
IRMD logo

IRADIMED CORPORATION Stock Price

NasdaqGM:IRMD Community·US$1.1b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

IRMD Share Price Performance

US$82.22
10.61 (14.82%)
​
US$118.00
Fair Value
US$82.22
10.61 (14.82%)
30.3% undervalued intrinsic discount
US$118.00
Fair Value
Price US$82.22
AnalystConsensusTarget US$118.00
Thu, 18 Jun 26
Fair ValueUS$118.00
Share Pricen/a

IRMD Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$118 30.3% undervalued intrinsic discount

IRMD: Index Addition and Strong Margins Will Support Measured Upside

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
IRMD logo
IRADIMED
30.3% undervalued intrinsic discount

IRMD: Index Addition and Strong Margins Will Support Measured Upside

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 18 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
IRMD logo

IRMD: 2026 Guidance And Bullish Initiation Will Drive Further Re Rating

Fair Value: US$118 30.3% undervalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet with proven track record.

0 Risks
2 Rewards
View Full Analysis

IRADIMED CORPORATION Key Details

US$86.3m

Revenue

US$20.8m

Cost of Revenue

US$65.5m

Gross Profit

US$42.4m

Other Expenses

US$23.1m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
1.80
75.86%
26.70%
0%
View Full Analysis

About IRMD

Founded
1992
Employees
166
CEO
Roger Susi
WebsiteView website
www.iradimed.com

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Recent IRMD News & Updates

Recent updates

No updates

IRADIMED CORPORATION Competitors

BLCO logo

Bausch + Lomb

Symbol: NYSE:BLCO
Market cap: US$6.2b
RDNT logo

RadNet

Symbol: NasdaqGM:RDNT
Market cap: US$5.9b
TFX logo

Teleflex

Symbol: NYSE:TFX
Market cap: US$5.6b
MMSI logo

Merit Medical Systems

Symbol: NasdaqGS:MMSI
Market cap: US$5.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide